VXRT

VXRT

USD

Vaxart Inc Common Stock

$0.504-0.086 (-14.516%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$0.590

Haut

$0.621

Bas

$0.491

Volume

2.68M

Fondamentaux de l'Entreprise

Capitalisation Boursière

115.0M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

3.50M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.28Actuel $0.504Haut $1.07

Actualités Connexes

GlobeNewswire

Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology

- Second-generation norovirus constructs produce statistically significant increases in GI.1 and GII.4 norovirus blocking antibodies (141% and 94%, respectively) compared with first-generation constructs, supporting

Voir plus
Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology
GlobeNewswire

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial

SOUTH SAN FRANCISCO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ:VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery

Voir plus
Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial
GlobeNewswire

Vaxart Announces Adjournment of Annual Meeting of Stockholders

Meeting adjourned to June 13, 2025 at 8:30 a.m. Pacific Time Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 12, 2025 Leading

Voir plus
Vaxart Announces Adjournment of Annual Meeting of Stockholders
GlobeNewswire

Vaxart's Founder and Chief Scientific Officer Provides Video Update to Stockholders

Dr. Sean Tucker, Founder and CSO of Vaxart, Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on June 1, 2025 Company Corrects Record on Common Misconceptions Regarding the Reverse

Voir plus
Vaxart's Founder and Chief Scientific Officer Provides Video Update to Stockholders
GlobeNewswire

Vaxart Answers Additional Frequently Asked Questions from Retail Investors

Company Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on June 1, 2025 SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ:VXRT) (the "Company"

Voir plus
Vaxart Answers Additional Frequently Asked Questions from Retail Investors

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.